Composition for treating cancer stem cells
AssigneeHaimbio Co., Ltd.
InventorsJae Ho Cheong, Eun Sung Park, Ki Cheong Park
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition for effectively treating cancer stem cells, and more specifically to a composition for treating cancer stem cells, which contains a glucose uptake inhibitor, a biguanide-based compound, and a calcium pump inhibitor. The composition of the present invention can be used as an agent of treating cancer stem cells by effectively inducing apoptosis of the cancer stem cells. Accordingly, the composition of the present invention can be used as a pharmaceutical composition capable of effectively treating various cancer stem cells to effectively inhibiting cancer recurrence and/or metastasis.
Claims6
A method for inhibiting breast cancer stem cell growth in a subject, comprising administering a glucose uptake inhibitor to the subject and a calcium pump inhibitor, wherein the glucose uptake inhibitor is 2-deoxyglucose (2DG) and the calcium pump inhibitor is caloxin 2a1.
A method for treating breast cancer stem cells in a subject, comprising administering a glucose uptake inhibitor and a calcium pump inhibitor to the subject, wherein the glucose uptake inhibitor is 2-deoxyglucose(2DG) and the calcium pump inhibitor is caloxin 2a1.
Dependencies are inferred from the claim text.